Viewing StudyNCT00203372



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00203372
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2005-09-12

Brief Title: Neoadjuvant TAC Plus or Minus BevacizumabAVF3299
Sponsor:
Organization: Translational Oncology Research International